The incoming interim president and chief executive officer of BioCrossroads says the transition in leadership will be a smooth one. The state’s life science initiative announced Wednesday longtime CEO David Johnson is leaving to continue his role as CEO of the Central Indiana Corporate Partnership on a full-time basis. Nora Doherty will assume the interim position at the beginning of the year and says BioCrossroads continues to look to the future.
"One of the big areas of focus that I think is going to be coming up in 2019 is understanding the convergence that is continuing to happen across all the industries, but especially in life sciences with data analytics and artificial intelligence," said Doherty. "That’s going to be a new area as we look to see how that impacts all of our stakeholders and I think there’s going to be interesting projects for that in 2019."
Doherty says the growth of the CICP, which is the parent of BioCrossroads and the other five sector initiatives in the state, made splitting CEO duties between the two organizations too difficult for Johnson to manage. She has been with BioCrossroads for 15 years and currently serves as senior vice president and managing director of the Indiana Seed Funds, from which she says efforts will also continue next year.
She says a nationwide search for Johnson’s permanent successor has already begun.